BVS
Bioventus Inc
13.10$
-2.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 15 | Q1 16 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +22.6% | +22.6% | +0.0% | +2.6% | +18.6% | -19.4% | -26.2% | +48.1% | +14.8% | -17.1% | +34.3% | -0.8% | +19.8% | -10.1% | +19.6% | -8.3% | -2.2% | -5.4% | +15.1% | -11.9% | +12.1% | -4.4% | +16.8% | -8.1% | +10.6% | -19.4% | +19.2% | -6.1% | +13.9% | -16.3% | +16.0% | – | |
| – | +14.4% | +17.3% | +0.0% | -3.9% | +11.3% | -11.3% | -17.5% | +32.7% | +7.2% | -11.5% | +50.8% | -11.0% | +43.0% | -2.5% | +5.0% | +1.0% | +17.0% | -12.6% | +6.2% | -12.5% | +17.1% | -16.4% | +15.8% | -4.6% | +12.3% | -16.8% | +10.8% | -2.5% | +10.0% | -15.8% | +12.1% | – | |
| – | +26.3% | +24.8% | +0.0% | +5.1% | +21.3% | -22.1% | -29.5% | +54.8% | +17.6% | -18.9% | +28.1% | +3.6% | +11.0% | -13.7% | +27.7% | -12.5% | -12.2% | -0.4% | +20.6% | -11.5% | +9.4% | +2.4% | +17.3% | -9.7% | +9.7% | -20.6% | +23.6% | -7.8% | +15.8% | -16.6% | +17.8% | – | |
| – | +25.4% | -31.9% | +0.0% | +12.4% | +10.5% | -31.7% | +21.0% | +37.5% | -19.0% | -67.2% | +410.7% | +27.2% | +15.4% | -2.5% | -8.1% | -27.5% | +47.5% | -44.6% | -9.9% | -11.3% | +8.2% | -19.5% | +60.3% | -9.5% | -14.8% | -7.2% | +5.3% | -7.8% | +2.9% | -18.0% | +28.6% | – | |
| – | – | – | – | – | – | -26.0% | +0.6% | +24.1% | +17.7% | +226.1% | -64.2% | +1.8% | +9.6% | +12.2% | +4.1% | -6.2% | -14.3% | +12.3% | -7.5% | -7.0% | +6.7% | +5.2% | +20.9% | -14.4% | +6.8% | -15.1% | +7.6% | -0.6% | +5.2% | -5.4% | +5.6% | – | |
| – | -9.1% | +12.4% | +0.0% | -7.6% | +19.4% | -25.9% | +1.6% | +23.6% | +21.7% | -44.4% | +118.5% | -2.4% | +13.5% | +6.9% | +2.9% | +111.5% | -52.9% | +66.6% | -50.4% | -7.2% | +11.4% | -2.0% | +61.9% | -33.8% | +5.8% | -19.2% | +7.2% | -1.6% | +6.2% | -5.8% | +7.1% | – | |
| – | – | – | +0.0% | +207.6% | +29.2% | -5.2% | -135.4% | – | -14.8% | +272.3% | -126.1% | – | – | – | – | – | – | – | – | -64.2% | -51.8% | +323.0% | -738.7% | – | +96.1% | -37.7% | +274.4% | -35.0% | +79.4% | -59.1% | +115.2% | – | |
| – | -7.8% | – | – | – | – | -68.9% | +19.0% | -33.7% | +41.3% | +8.3% | -41.6% | -19.9% | -28.7% | -30.6% | +287.1% | +39.8% | +312.7% | -34.8% | +9.2% | -4.5% | +1.6% | +0.6% | -4.0% | -4.0% | -5.6% | -16.5% | -0.2% | -17.6% | -14.1% | -18.5% | -6.0% | – | |
| – | – | – | – | – | +3.8% | +69.6% | -157.9% | – | -62.3% | +678.6% | -137.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,572.8% | – | -54.7% | +202.8% | -68.1% | +238.9% | – | |
| – | +63.4% | -73.9% | +0.0% | +134.3% | +141.7% | -95.6% | -382.1% | – | +138.6% | -108.2% | – | -151.5% | – | – | – | -2,473.2% | – | – | – | +57.5% | -225.0% | – | -909.2% | – | -6.6% | -117.3% | – | -36.2% | -578.2% | – | -3,759.7% | – | |
| – | – | – | – | – | +35.7% | +94.1% | -152.7% | – | -67.2% | +798.3% | -116.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -57.7% | +367.7% | -78.9% | +974.2% | – | |
| – | +300.2% | -3.3% | +0.0% | +116.7% | +18.0% | -4.4% | -86.9% | +558.9% | -27.7% | +130.7% | -72.4% | -16.6% | +19.6% | -201.2% | – | -1,438.1% | – | – | – | -24.4% | -9.0% | +16.1% | -211.4% | – | +27.4% | -26.2% | +87.1% | -25.5% | +40.0% | -35.6% | -3.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.